Evaluation of Eye Health Benefits of Blueberry Chewable Tablets
NCT ID: NCT04348110
Last Updated: 2021-01-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
57 participants
INTERVENTIONAL
2020-04-17
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Investigation Into the Effects of a Wild Blueberry Powder and a Wild Blueberry Extract on Cognition in Older Adults
NCT02446314
Long-term Effects of Blueberry Supplementation on Brain Health in Older Adults
NCT05764824
The Effects of a Single Dose of Wild Blueberries on Mood and Cognition in Healthy Young Adults
NCT04935099
Efficacy and Tolerability of a Bilberry Extract in Volunteers With Impaired Twilight and Night Vision
NCT02194127
Investigating the Acute Effects of Blueberry (Poly)Phenols on Vascular Function and Cognition in Healthy Individuals.
NCT03592966
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo tablets
Placebo tablets
consume 2 tablets per day for 8 weeks
Blueberry Chewable Tablets
Blueberry Chewable Tablets
consume 2 tablets per day for 8 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo tablets
consume 2 tablets per day for 8 weeks
Blueberry Chewable Tablets
consume 2 tablets per day for 8 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Use 3C products over 6 hours per day
* Symptoms of dry eyes or tired eyes
* Tear Break-Up Time is 10 seconds less
* No history of ocular surgery (strabismus surgery, refractive surgery etc.)
Exclusion Criteria
* Long-term use of drugs or eye drops that affect the condition of the front surface of the eyes
* Long-term contact lens wear
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TCI Co., Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bo-Yie Chen
Role: PRINCIPAL_INVESTIGATOR
Chung Shan Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chung Shan Medical University
Taichung, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CS19152
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.